Molecular Medicine & Pathology seminar: Discovery of inhibitors of OXPHOS in mycobacterium tuberculosis: A game changer in the fight against MDR and XDR tuberculosis disease Event as iCalendar

12 September 2013

3:30 - 4:30pm

Venue: Seminar Room 501-505, Building 501, 85 Park Road, Grafton

New drugs are urgently needed to shorten the treatment period for tuberculosis (TB), to address persistence, and to deal with the increasing incidence of multi- (MDR) and extensively-drug resistant (XDR) TB. A game changer in the fight against MDR and XDR TB has been the discovery of bedaquiline, the first TB drug licensed in 40 years. In this presentation I will discuss the mode of action of bedaquiline and the discovery of new compounds that target the process of oxidative phosphorylation in mycobacteria.

Speaker : Professor Gregory M. Cook (Department of Microbiology and Immunology, University of Otago)

Anyone wanting to meet with Professor Cook should email Robyn McDonald (email: r.mcdonald@auckland.acnz )